Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Hosp

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|July 13, 2017
Safety of available and emerging drug therapies for hyperhidrosisChristine Hosp, Henning Hamm
Seminars in Neurology|February 12, 2016
Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and SialorrheaChristine Hosp, Markus K Naumann, Henning Hamm
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 26, 2018
Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implicationsJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 4, 2014
Risk stratification of systemic allergic reactions during Hymenoptera venom immunotherapy buildup phaseJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Christine Hosp, Matthias Goebeler, Sandrine Benoit, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 9, 2015
Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effectiveJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 14, 2020
Rituximab-mediated late onset neutropenia in autoimmune blistering diseases: negligible or under-estimated threat?Christine Hosp, Matthias Goebeler, Sandrine Benoit, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 15, 2017
Safety of 100 µg venom immunotherapy rush protocols in children compared to adultsJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Plos One|August 22, 2009
Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptorsGerhard Rammes, Christine Hosp, Brigitte Eisensamer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|July 13, 2017
Safety of available and emerging drug therapies for hyperhidrosisChristine Hosp, Henning Hamm
Seminars in Neurology|February 12, 2016
Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and SialorrheaChristine Hosp, Markus K Naumann, Henning Hamm
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 26, 2018
Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implicationsJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 4, 2014
Risk stratification of systemic allergic reactions during Hymenoptera venom immunotherapy buildup phaseJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Christine Hosp, Matthias Goebeler, Sandrine Benoit, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 9, 2015
Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effectiveJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 14, 2020
Rituximab-mediated late onset neutropenia in autoimmune blistering diseases: negligible or under-estimated threat?Christine Hosp, Matthias Goebeler, Sandrine Benoit, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 15, 2017
Safety of 100 µg venom immunotherapy rush protocols in children compared to adultsJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Plos One|August 22, 2009
Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptorsGerhard Rammes, Christine Hosp, Brigitte Eisensamer, et al.
Pageof 1